P2Y6 Deficiency Enhances Dendritic Cell–Mediated Th1/Th17 Differentiation and Aggravates Experimental Autoimmune Encephalomyelitis
Author(s) -
Zhenlong Li,
Cong He,
Jiang Zhang,
Hongmei Zhang,
Huan Wei,
Shijia Wu,
Wenzheng Jiang
Publication year - 2020
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.1900916
Subject(s) - experimental autoimmune encephalomyelitis , immunology , dendritic cell , encephalomyelitis , cellular differentiation , medicine , multiple sclerosis , biology , neuroscience , immune system , genetics , gene
Dendritic cells (DCs) are essential APCs and play a crucial role in initiating and regulating the adaptive immune response. In this study, we have reported that P2Y 6 , a member of G protein-coupled receptors, inhibits the maturation and activation of DCs via suppressing the activation of the transcription factor NF-κB. Furthermore, loss of P2Y 6 does not impact T cells homeostasis in the steady-state. However, in vitro studies show that P2Y 6 signaling inhibits the production of IL-12 and IL-23 and the polarization of Th1 and Th17 subsets mediated by DCs. In addition, we find that mice lacking P2Y 6 develop more severe experimental autoimmune encephalomyelitis compared with wild-type mice. Our results indicate that P2Y 6 functions as a pivotal regulator on DC maturation, and the loss of P2Y 6 results in the aggravated experimental autoimmune encephalomyelitis, which suggests that P2Y 6 may play a pivotal role in the pathogenesis of autoimmune diseases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom